Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Bionano Genomics, Inc. (BNGO)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-K10-KS-1/A
Net income  -132.6-72.4-41.1-29.8-18.5-23.40.0
Depreciation and amortization  9.63.41.51.11.31.51.1
Asset impairment charges    0.1 1.31.0 
Stock-based compensation  22.49.71.61.31.20.40.1
Deferred taxes  1.8-5.8     
Change in working capital   [+]-0.15.9-3.41.83.2-7.4-3.0
Other operating activities  -25.9-12.73.1-4.0-8.57.1-21.8
Cash from operations  -124.8-71.9-38.3-29.5-19.9-20.8-23.5
   
Capital expenditures   [+]-2.4-0.80.0-0.1-0.3-1.0-1.3
Purchases of intangible assets  -0.1      
Purchases of short-term investments, net  139.5-226.9     
Other cash from investing  -54.2-50.3-2.5    
Cash from investing  82.8-278.1-2.5-0.1-0.3-1.0-1.3
   
Issuance of common stock, net  23.1342.739.919.619.4  
Option exercises       0.0 
Other cash from financing  -0.1-6.622.010.816.417.625.4
Cash from financing  23.0336.161.930.435.817.625.4
   
Free cash flow  -127.2-72.7-38.3-29.6-20.3-21.8-24.8
        Per share (diluted)  ($0.44)($0.26)($0.37)($1.98)($2.86)($8.08)($0.41)
   
Cash paid for interest  0.31.91.31.30.70.5 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy